Digitoxin, Serum/Plasma Test (1613SP)
| Analysis Code |
1613SP |
| Test Name |
Digitoxin, Serum/Plasma |
| Test Includes |
Digitoxin |
| Purpose |
Therapeutic Drug Monitoring; This test is New York State approved. |
| Category |
Cardiovascular |
| Method(s) |
Immunoassay (IA) |
| Specimen Requirements |
1 mL Serum or Plasma |
| Transport Temperature |
Refrigerated |
| Specimen Container |
Plastic container (preservative-free) |
| Special Handling |
Promptly centrifuge and separate Serum or Plasma into a plastic screw capped vial using approved guidelines. |
| Light Protection Required |
Not Required |
| Stability |
Room Temperature: Undetermined
Refrigerated: 7 day(s)
Frozen (-20 °C): 3 month(s) |
| *Rejection Criteria |
Polymer gel separation tube (SST or PST). |
| Day(s) Test Set-up / TAT |
[IA] Monday-Sunday / 4 days |
| Suggested CPT Code |
80375 |
| **Minimum Volume |
0.4 mL |
| Test Summary Sheet |
Generate
|
You are viewing Digitoxin, Serum/Plasma Test (1613SP)
*Rejection criteria pertain to clinical specimen submissions only.
**Stated minimum volume allows for a single analysis. Repeat analysis will not be performed.